Free Trial

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

Fresenius Medical Care AG & Co. KGaA logo
$26.55 -0.44 (-1.63%)
Closing price 03:59 PM Eastern
Extended Trading
$26.56 +0.01 (+0.04%)
As of 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FMS vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and HIMS

Should you be buying Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? The main competitors of Fresenius Medical Care AG & Co. KGaA include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

Fresenius Medical Care AG & Co. KGaA vs. Its Competitors

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

In the previous week, Fresenius Medical Care AG & Co. KGaA had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for Fresenius Medical Care AG & Co. KGaA and 0 mentions for Aclarion. Aclarion's average media sentiment score of 1.89 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Aclarion is being referred to more favorably in the news media.

Company Overall Sentiment
Fresenius Medical Care AG & Co. KGaA Neutral
Aclarion Very Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Aclarion.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$19.49B0.80$582.08M$1.1223.71
Aclarion$54.60KN/AN/AN/AN/A

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $27.80, suggesting a potential upside of 4.71%. Given Fresenius Medical Care AG & Co. KGaA's stronger consensus rating and higher probable upside, equities research analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Aclarion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aclarion
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Fresenius Medical Care AG & Co. KGaA has a net margin of 3.18% compared to Aclarion's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.25% beat Aclarion's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA3.18% 6.25% 2.88%
Aclarion N/A N/A N/A

Summary

Fresenius Medical Care AG & Co. KGaA beats Aclarion on 9 of the 10 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

MetricFresenius Medical Care AG & Co. KGaAMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$15.84B$6.63B$5.54B$20.85B
Dividend Yield2.09%1.30%3.75%3.65%
P/E Ratio23.7125.1728.0127.55
Price / Sales0.8062.25432.7259.17
Price / Cash5.5420.3736.1622.29
Price / Book0.914.608.124.66
Net Income$582.08M$174.76M$3.25B$994.58M
7 Day Performance-1.81%0.40%0.97%-0.29%
1 Month Performance-1.25%2.10%7.36%4.91%
1 Year Performance32.95%3.32%31.31%10.53%

Fresenius Medical Care AG & Co. KGaA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care AG & Co. KGaA
3.0731 of 5 stars
$26.55
-1.6%
$27.80
+4.7%
+36.6%$15.84B$19.49B23.711,384
ACONW
Aclarion
N/A$0.03
-18.2%
N/A-12.9%$0.00$54.60K0.007
AONC
American Oncology Network
N/A$13.50
+3.8%
N/A+704.8%$0.00$1.34B0.001,520Gap Down
DHACW
Digital Health Acquisition
N/A$0.04
-14.7%
N/A-67.8%$0.00N/A0.00N/A
LFMDP
LifeMD
N/A$24.02
-0.1%
N/A+0.6%$0.00$234.01M0.00230Positive News
OTRKP
Ontrak
N/A$0.24
+4.5%
N/AN/A$0.00$10.84M0.00250High Trading Volume
PIIIW
P3 Health Partners
N/A$0.01
-5.9%
N/AN/A$0.00$1.49B0.00500Gap Down
TALKW
Talkspace
N/A$0.09
-11.7%
N/A-34.2%$0.00$194.36M0.00500Gap Down
TOIIW
Oncology Institute
N/A$0.07
+8.5%
N/A+297.9%$0.00$403.15M0.00660Gap Up
NTRA
Natera
2.7126 of 5 stars
$158.69
-1.9%
$184.63
+16.3%
+29.9%$21.67B$1.70B-107.954,434
HIMS
Hims & Hers Health
2.271 of 5 stars
$48.34
+0.8%
$39.58
-18.1%
+127.5%$10.82B$1.78B70.061,637Trending News
Analyst Forecast
Insider Trade

Related Companies and Tools


This page (NYSE:FMS) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners